In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-7 of 7 for your search:
Drug:  gp100:209-217(210M) peptide vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000068299, NCI-00-C-0216, NCI-2391, 2391, NCT00020358

2.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000068514, NCI-01-C-0074, NCI-2910, 2910, NCT00020475

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000069251, NCI-02-C-0106H, NCI-5743, 5743, NCT00032045

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: CDR0000335441, NCI-03-C-0299, NCI-6210, 6210, NCT00072085

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: 10M-03-1, LAC-USC-10M-03-1, NCI-6262, LAC-USC-033307, CDR0000480137, NCI-2009-00050, 6262, NCT00334776

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: NCI-06-C-0159, NCI-P6951, MDX-NCI-06-C-0159, NCT00357461

7.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000544402, PCI-04173, PCI-IRB-0607048, 04-173, 7357, NCT00471471
New Search